Impact of Cytogenetic Risk on Outcomes of Non-T-Cell–Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Impact of Cytogenetic Risk on Outcomes of Non-T-Cell–Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Published:2022-11 Issue:11 Volume:28 Page:773.e1-773.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Nagler Arnon,Labopin Myriam,Dholaria Bhagirathbhai^ORCID,Ciceri Fabio,Fraccaroli Alessia,Blaise Didier^ORCID,Fanin Renato,Bruno Benedetto^ORCID,Forcade Edouard,Vydra Jan^ORCID,Chevallier Patrice,Bulabois Claude Eric,Jindra Pavel,Bornhäuser Martin,Canaani Jonathan^ORCID,Sanz Jaime,Savani Bipin N.,Spyridonidis Alexandros^ORCID,Giebel Sebastian,Brissot Eolia,Bazarbachi Ali,Esteve Jordi,Mohty Mohamad

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference43 articles.

1. Acute Myeloid Leukemia;Döhner;N Engl J Med.,2015

2. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century;Pulte;Blood Cancer J,2020

3. Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia;Schlenk;Leukemia,2017

4. Treatment of relapsed acute myeloid leukemia;Thol;Curr Treat Options Oncol,2020

5. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report;Passweg;Bone Marrow Transplant,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of anti-thymocyte globulin in allogeneic stem cell transplantation (HSCT) from HLA-matched unrelated donors (MUD) for secondary AML in remission: a study from the ALWP /EBMT;Bone Marrow Transplantation;2023-09-02

2. Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT;Journal of Hematology & Oncology;2023-05-29

3. Allogeneic stem cell transplantation in the treatment of acute myeloid leukemia: An overview of obstacles and opportunities;World Journal of Clinical Cases;2023-01-16